(Press-News.org) A consortium of Birmingham researchers, clinicians and industry partners has received a second £1.1m award from the National Institute for Health and Care Research (NIHR) for a three-year study supporting the further development of a novel device that could revolutionise the clinical management of anal fistula.
In this intrusive and embarrassing condition, sufferers experience daily discomfort and smelly discharge from a tunnel between the bowel and skin around the anus. It affects mostly young people and has a significant impact on employment and family life due to chronic infection and pain.
Over 12,000 people a year are diagnosed in the UK, and it is notoriously difficult to treat. The clinical challenge is to allow the fistula tract to drain and heal at the same time and preserve continence. Current treatment pathways require multiple operations under general anaesthetic, over a prolonged timeframe and usually lead to hygiene difficulties, which can be permanent.
The consortium, which comprises experts from University Hospitals Birmingham NHS Trust, the University of Birmingham, and industry partners Neotherix and Keighleycolo has developed a novel device (known currently as the “Seton-Scaffold Device”), which is less invasive and more effective than existing treatments. The device combines a bioresorbable scaffold to heal the fistula and a thin comfortable seton to achieve drainage.
The device is made from a material that encourages the body’s cells to migrate, settle into and populate the scaffold. This is the first step in a process that should eventually lead to the complete healing of the fistula, and the scaffold material and seton thread are slowly resorbed over several weeks. The device can be delivered to the awake patient so making it a safer, and cheaper, alternative than the current treatment paradigm.
This Product Development Award from NIHR invention for innovation (i4i) programme will enable the consortium to finalise product design, manufacture sterile devices and conduct a pivotal clinical study across 10 hospitals in the UK to demonstrate the clinical safety and healing endpoints of the device in over 100 patients with anal fistula, including those with Crohn’s disease.
This is the second NIHR award for the consortium. Work funded by the previous award included education, training and usability sessions and a 20 patient study that showed the device is safe to use, and has good patient and clinician acceptance.
The consortium is now exploring commercialisation opportunities and the most effective route to market for this innovative, affordable device. Interested parties should contact University of Birmingham Enterprise.
Chief Investigator Professor Tom Pinkney from the University’s Institute of Applied Health Research said: “I am delighted that the NIHR continues to support the development of this much-needed innovation. Our data from a small first-in-man study demonstrated this device could be more effective than anything else on the market and make a real difference to patients’ lives.”
Neotherix CEO Dr Mike Raxworthy said: “This project will generate data critical to demonstrating the safety and clinical value of the Seton-Scaffold Device and will allow us to move forward with commercial partners. It is an excellent illustration of the value of a strong academic-clinical-industry collaboration working together to solve unmet medical needs.”
Professor Mike Keighley of Keighleycolo Ltd, and author of the definitive colorectal textbook (now in its 4th edition) said: “I believe this will deliver affordable and effective therapy without morbidity and the need for hospital admission worldwide.”
END
Further funding for new device to improve treatment of anal fistula
2024-02-15
ELSE PRESS RELEASES FROM THIS DATE:
Amsterdam UMC to use e-health tool to remotely monitor heart patients at home
2024-02-15
From today, patients and doctors at Amsterdam UMC's Heart Centre can make use of the app HartWacht (HeartGuard, in English) to supplement their care. Through the use of a small measurement instrument, around the size of a cereal bar, and a mobile app, patients can now have their blood pressure and arrythmias monitored at home. This means that patients need to visit their cardiologist less frequently. For doctors, this means they have more precise measurements and can act quicker where necessary. A ''win-win'' in the eyes of Michiel Winter, cardiologist at Amsterdam UMC and leader of this project.
"HartWacht ...
Proteins guide electrons to the right place
2024-02-15
Cells need energy to function. Researchers at the University of Gothenburg can now explain how energy is guided in the cell by small atomic movements to reach its destination in the protein. Imitating these structural changes of the proteins could lead to more efficient solar cells in the future.
The sun’s rays are the basis for all the energy that creates life on Earth. Photosynthesis in plants is a prime example, where solar energy is needed for the plant to grow. Special proteins absorb the sun’s rays, and the energy is transported as electrons inside the protein, in a process called charge transfer. In a new study, researchers show how ...
Language and culture may influence how our brain processes emotional faces
2024-02-15
Body language and the understanding thereof is a crucial part of communication. It is often assumed that humans can innately recognize other’s emotions, but there is growing evidence that the ability to decipher these emotions is not instinctive but shaped by people’s culturally shared understanding of emotions.
A team of scientists in the US decided to investigate how cultural upbringing and access to emotion category words, which categorize and facilitate access to a complex set of emotional ideas, experiences, and responses ...
New peer-reviewed EWG study finds little-known toxic crop chemical in four out of five people tested
2024-02-15
WASHINGTON – A new Environmental Working Group peer-reviewed study has found chlormequat, a little-known pesticide, in four out of five people tested. Because the chemical is linked to reproductive and developmental problems in animal studies, the findings suggest the potential for similar harm to humans.
EWG’s research, published February 15 in the Journal of Exposure Science and Environmental Epidemiology, tested the urine of 96 people for the presence of chlormequat, finding it in 77 of them. EWG summarized the findings in an article published on its website.
“EWG’s new study on chlormequat ...
Antidepressant use lower in moms who have support from grandparents
2024-02-15
Mothers are less likely to take antidepressants if their own parents and parents-in-law are healthy and live close by– a new study finds.
On the flip side of the coin, antidepressant use was highest in mothers whose parents and parents-in-law were elderly, in poor health, and lived far away – possibly due to the stress caused by needing to care for and support older grandparents instead of receiving help from them.
The findings of this new longitudinal study which tracked 488,000 mothers of young children between 2000-2014 are published today in the peer-reviewed journal Population Studies.
“Previous studies have consistently shown that younger grandparents in good ...
Experts call for innovative strategies to address global blood crisis, form blood D.E.S.E.R.T coalition
2024-02-15
KEY TAKEAWAYS
The majority of the world’s people live in what are known as “blood deserts,” areas in which the clinical need for blood components cannot be met in at least 75% of cases.
A global coalition of experts led by researchers from the Brigham identified urgent steps that can be taken by health systems to improve access to blood until longer term strategies are established
Billions of people live in parts of the world that are so remote from the nearest hospital facility with a functioning blood bank that they are termed “blood deserts.” Researchers from Brigham and Women’s Hospital, a founding member of the ...
Walking, jogging, yoga and strength training ease depression
2024-02-15
Walking or jogging, yoga, and strength training seem to be the most effective exercises to ease depression, either alone or alongside established treatments such as psychotherapy and drugs, suggests an evidence review published by The BMJ today.
Even low intensity activities such as walking or yoga are beneficial, but the results suggest that the more vigorous the activity, the greater the benefits are likely to be.
The authors stress that confidence in many of the findings remains low ...
Doctors quitting over stress and cost of finding suitable childcare
2024-02-15
Securing suitable childcare for the irregular and long working hours demanded by a medical career is a crippling financial burden and a draining source of stress for doctor parents, reveals an exclusive snapshot survey by The BMJ today.
Some doctors have resigned or are considering resigning, others have changed specialities in the hope that it gives them more flexibility, and yet more altered their plans to have children as a result, reports health journalist Erin Dean.
The BMJ Childcare Survey ran on bmj.com from 16 to 30 November ...
Companies are adopting feminist narratives to influence women’s health
2024-02-15
Feminist health narratives are being co-opted by commercial interests to market new technologies, tests, and treatments that are not backed by evidence, argue researchers in The BMJ today.
Dr Tessa Copp at The University of Sydney and colleagues say such marketing behaviour risks harming women through inappropriate medicalisation, overdiagnosis, and overtreatment.
They call for greater wariness of simplistic health messages that any knowledge is power, and urge health professionals and governments ...
The BMJ reveals huge delays in dealing with complaints against UK drug companies
2024-02-15
Processing times for complaints against drug companies suspected of having breached their industry code of practice have more than tripled in a nearly two-decade period, an investigation by The BMJ has found.
Data analysis by Shai Mulinari at Lund University and Piotr Ozieranski at the University of Bath show that the average processing time of a complaint more than tripled between 2004-2021, from less than three months to more than 8.5 months. Numerous complaints have taken more than a year ...